Prairiewood Capital’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-16,609
| Closed | -$213K | – | 77 |
|
|
2022
Q3 | $213K | Sell |
16,609
-241,012
| -94% | -$3.09M | 0.18% | 71 |
|
|
2022
Q2 | $1.81M | Sell |
257,621
-452
| -0.2% | -$3.17K | 1.43% | 19 |
|
|
2022
Q1 | $2.14M | Sell |
258,073
-3,330
| -1% | -$27.6K | 1.5% | 19 |
|
|
2021
Q4 | $1.77M | Sell |
261,403
-6,034
| -2% | -$40.9K | 1.4% | 20 |
|
|
2021
Q3 | $1.42M | Buy |
267,437
+10,871
| +4% | +$57.6K | 1.16% | 21 |
|
|
2021
Q2 | $1.48M | Buy |
256,566
+1,300
| +0.5% | +$7.47K | 1.26% | 20 |
|
|
2021
Q1 | $1.18M | Buy |
255,266
+41,834
| +20% | +$193K | 1.08% | 24 |
|
|
2020
Q4 | $713K | Buy |
+213,432
| New | +$713K | 0.73% | 43 |
|